Insider Transactions Reported by 24 Insiders of Metacrine, Inc.

Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 07 Jan 2025

Metacrine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden M. Leonard 10%+ Owner $3,177,468 19 Dec 2022
Ali Behbahani 10%+ Owner $1,204,731 10 Dec 2021
Carmen Chang 10%+ Owner $1,204,731 10 Dec 2021
Anthony A. Florence Jr. 10%+ Owner $1,204,731 10 Dec 2021
Mohamad Makhzoumi 10%+ Owner $1,204,731 10 Dec 2021
Peter W. Sonsini 10%+ Owner $1,204,731 10 Dec 2021
SCOTT D. SANDELL 10%+ Owner $1,204,731 10 Dec 2021
Paul Edward Walker 10%+ Owner $1,204,731 10 Dec 2021
New Enterprise Associates 16, L.P. 10%+ Owner $1,204,731 10 Dec 2021
FOREST BASKETT 10%+ Owner $1,204,731 10 Dec 2021
venBio Global Strategic Fund, L.P. 10%+ Owner $1,148,408 22 Oct 2021
Preston Klassen Director $650,535 23 Mar 2023
Trisha Millican Chief Financial Officer $51,249 05 May 2021
Michael York Chief Business Officer $48,645 26 Jan 2023
Catherine C. Lee EVP, Gen. Counsel & Secretary $1,808 05 May 2021
Hubert C. Chen Chief Medical Officer $1,546 20 May 2021
JEFFREY DAVID JONKER Director 18 May 2022
Amir Nashat Director, 10%+ Owner 18 May 2022
Julia C. Owens Director 18 May 2022
Ronald M. Evans Director 18 May 2022
Richard A. Heyman Director 18 May 2022
Kristina Burow Director 24 May 2021
ANDREW GUGGENHIME Director 18 May 2022
John G. McHutchison Director 18 May 2022

Recent Insider Transactions by Companies or Individuals for Metacrine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.